Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (211-220 of 365) with videos related to

Pageof 37
Sort By:
The Neurologist|September 13, 2007
Caffeine for the prevention and treatment of postdural puncture headache: debunking the mythRashmi B Halker, Bart M Demaerschalk, Kay E Wellik, et al.
Cephalalgia : an International Journal of Headache|June 9, 2016
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraineTiffini Voss, Richard B Lipton, David W Dodick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 2019
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysisPeter J Goadsby, David W Dodick, James M Martinez, et al.
Headache|October 21, 2018
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender DifferencesRichard B Lipton, Sagar Munjal, Aftab Alam, et al.
The Journal of Headache and Pain|May 26, 2018
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) studyTodd J Schwedt, Aftab Alam, Michael L Reed, et al.
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
Headache|May 22, 2021
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey studyChia-Chun Chiang, Rashmi Halker Singh, Nim Lalvani, et al.
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.
Headache|August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
The Journal of Headache and Pain|September 29, 2022
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?Caroline M Kopruszinski, Robson Vizin, Moe Watanabe, et al.
Pageof 37

Showing results (211-220 of 365) with videos related to

Sort By:
Pageof 37
The Neurologist|September 13, 2007
Caffeine for the prevention and treatment of postdural puncture headache: debunking the mythRashmi B Halker, Bart M Demaerschalk, Kay E Wellik, et al.
Cephalalgia : an International Journal of Headache|June 9, 2016
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraineTiffini Voss, Richard B Lipton, David W Dodick, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 2019
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysisPeter J Goadsby, David W Dodick, James M Martinez, et al.
Headache|October 21, 2018
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender DifferencesRichard B Lipton, Sagar Munjal, Aftab Alam, et al.
The Journal of Headache and Pain|May 26, 2018
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) studyTodd J Schwedt, Aftab Alam, Michael L Reed, et al.
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
Headache|May 22, 2021
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey studyChia-Chun Chiang, Rashmi Halker Singh, Nim Lalvani, et al.
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.
Headache|August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
The Journal of Headache and Pain|September 29, 2022
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?Caroline M Kopruszinski, Robson Vizin, Moe Watanabe, et al.
Pageof 37